News

AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...
There’s no shortage of big promises about AI in healthcare. The U.S. government announced a $500 billion Stargate initiative ...
AI startup ByteBrain is transforming clinical trials with agent-based optimization, cutting costs, boosting efficiency, and ...
To create truly adaptable strategies, you have to hammer out the core problems and explore multiple solutions.
The technology’s potential to transform trials will need to be balanced with the challenge of instilling trust in ...
Prestigious international annual awards program recognizes standout digital health and medical technology products and ...
Industry experts gathered at the Outsourcing in Clinical Trials East Coast 2025 conference to discuss artificial intelligence ...
Discover how digital innovation in clinical trial technology—eClinical platforms, remote data capture, and decentralized ...
The landscape of clinical trials is rapidly transforming. As we move through 2025, smarter technologies and patient-centric ...
During a panel discussion on AI in clinical research, Prasanna Rao, Chief Products and Innovation officer at Saama emphasised the importance of making protocol data available to large language ...
Neuroscience technology company Brooklyn Health is using artificial intelligence to target a fundamental problem in neurology ...
Key Takeaways AI accelerates drug approvals in 2025 by streamlining clinical data analysis.Advanced AI tools reduce costs and time for new medicine development.